Donghoon Lee

Mr. Lee is currently a head of Bio Investment Center at SK Inc, an investment holding company of SK group.

He is leading SK group’s bio investment globally by serving as a chairman of BOD at SK Biopharm and as a board member at SK Pharmteco.

Formerly, he was a head of global business at Donga ST and CEO of Donga Socio Holdings.

Prior to joining Donga, he practiced as a partner at Samjong KPMG Investment Advisory in Korea.

He has MBA from The Ohio State University and BBA from Seoul National University.